Record Harvest and Expansion of Premium B2C Product Line
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The company anticipates exceeding previous production levels, with a notable increase in higher-value premium dried flower. ECS is also launching new strains under the Terphogz brand and expects to enter international markets, including the UK and Germany. The outlook remains positive, with forecasts for steady sales growth and a return to cash flow positive status in the near future.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Ecs Botanics Holdings Ltd on 6ix
Story so far
Earlier from Ecs Botanics
- Quarterly Activities/Appendix 4C Cash Flow Report (amended)
- ECS Secures Additional Growth Funding
- ECS Half Year FY25 Results
- ECS Achieves 50% Yield Increase with New PCEs
- ECS loan increase by NAB and VESIsorb launch
Later from Ecs Botanics
- Terphogz Launch
- ECS to support UWA medicinal cannabis clinical trial
- Appendix 4E & Annual Report
- ECS FY25 Results
- Trading Halt
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics